Aignostics
Aignostics is a global artificial intelligence company specializing in transforming complex multi-modal pathology data into actionable insights. The company focuses on developing advanced AI models for pathology, collaborating with leading institutions like Mayo Clinic to enhance its offerings for biopharmaceutical clients. Aignostics is expanding its presence in the United States and aims to innovate within the pathology domain through its cutting-edge foundation models.
Leadership & Board
- Current Number of Employees
- 106
- Current LinkedIn Followers
- 12,178
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $34M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $34M
- Latest Funding Round
- Series B
- Post-Money Valuation
- ―
Company Momentum Positive
Aignostics LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.
Employee Trend
Aignostics had 106 employees as of October 12, 2026. The number of employees decreased by 5 (4.50%) week-over-week.
Social Trend
Aignostics had 12,178 followers as of October 12, 2026. The number of followers increased by 28 (0.23%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series B | $34.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| ATHOS | Series B |
| Mayo Clinic | Series B |
| HTGF | Series B |
| Wellington Partners | Series B |
| Boehringer Ingelheim Venture Fund | Series B |
| CARMA Fund | Series B |
| VC Fonds Technologie managed by IBB Ventures | Series B |
Similar Companies
A snapshot of private companies similar to Aignostics, helping you discover and navigate related company profiles.
Related News and Analysis
